Skip to main content
Erschienen in: Journal of Cancer Research and Clinical Oncology 2/2017

24.10.2016 | Original Article – Clinical Oncology

Left-sided laterality of Merkel cell carcinoma in a German population: more than just sun exposure

verfasst von: T. Gambichler, U. Wieland, S. Silling, M. Dreißigacker, J. Schaller, H.-J. Schulze, F. Oellig, A. Kreuter, M. Stücker, F. G. Bechara, E. Stockfleth, J. C. Becker

Erschienen in: Journal of Cancer Research and Clinical Oncology | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Abstract

Background

Lateral distribution of cancer has been observed previously. Most evident is this laterality in ultraviolet (UV)-induced skin cancer, based on an unequally distributed UV exposure.

Objectives

The aim of this study was to explore whether patients from Germany also show asymmetrical lateral distribution of Merkel cell carcinoma (MCC).

Methods

In total, 115 patients with MCC were studied for laterality of the primary tumour. Correlation of clinical variables with lateral distribution of MCC was investigated as well.

Results

In 64/115 (55.7%) patients, primary tumours were present on the left side, in 37/115 (32.2%) on the right side, and in 14/115 (12.2%) in the midline (P < 0.0001). Excluding the latter localization occurrence of left-sided MCCs (64 of 101/63.4%) was significantly (P = 0.0072) more often observed (1.73–fold) when compared to right-sided tumours (37 of 101/36.6%). The excess of left-sided tumours was found on the head with a left–right ratio of 1.8, trunk of 8, arm of 1.2, and leg of 1.8. There was no significant association between laterality and gender, age, MCPyV status, and anatomic localization of primary tumours including the occurrence in sun-exposed sites.

Conclusions

Occurrence of left-sided MCCs was significantly more often observed when compared to right-sided tumours. Laterality was not associated with tumour presentation at chronically ultraviolet-exposed sites. Hence, the reason for laterality in MCC remains obscure, but likely goes beyond UV exposure.
Literatur
Zurück zum Zitat Becker JC, Assaf C, Vordermark D, Reske SN, Hense J, Dettenborn T, Seitz O, Grabbe S (2013) Brief S2 k guidelines—Merkel cell carcinoma. J Dtsch Dermatol Ges 11(3):29–36CrossRefPubMed Becker JC, Assaf C, Vordermark D, Reske SN, Hense J, Dettenborn T, Seitz O, Grabbe S (2013) Brief S2 k guidelines—Merkel cell carcinoma. J Dtsch Dermatol Ges 11(3):29–36CrossRefPubMed
Zurück zum Zitat Bodenstine TM, Chandler GS, Seftor RE, Seftor EA, Hendrix MJ (2016) Plasticity underlies tumor progression: role of nodal signaling. Cancer Metastasis Rev 35:21–39CrossRefPubMed Bodenstine TM, Chandler GS, Seftor RE, Seftor EA, Hendrix MJ (2016) Plasticity underlies tumor progression: role of nodal signaling. Cancer Metastasis Rev 35:21–39CrossRefPubMed
Zurück zum Zitat Brewster DH, Horner MJ, Rowan S, Jelfs P, de Vries E, Pukkala E (2007) Left-sided excess of invasive cutaneous melanoma in six countries. Eur J Cancer 43:2634–2637CrossRefPubMed Brewster DH, Horner MJ, Rowan S, Jelfs P, de Vries E, Pukkala E (2007) Left-sided excess of invasive cutaneous melanoma in six countries. Eur J Cancer 43:2634–2637CrossRefPubMed
Zurück zum Zitat Bulliard JL, Ess S, Bordoni A, Konzelmann I, Levi F (2008) Left-sided excess in the laterality of cutaneous melanoma. Arch Dermatol 144:556–558CrossRefPubMed Bulliard JL, Ess S, Bordoni A, Konzelmann I, Levi F (2008) Left-sided excess in the laterality of cutaneous melanoma. Arch Dermatol 144:556–558CrossRefPubMed
Zurück zum Zitat Butler ST, Fosko SW (2010) Increased prevalence of left-sided skin cancers. J Am Acad Dermatol 63:1006–1010CrossRefPubMed Butler ST, Fosko SW (2010) Increased prevalence of left-sided skin cancers. J Am Acad Dermatol 63:1006–1010CrossRefPubMed
Zurück zum Zitat Fitzgerald TL, Dennis S, Kachare SD, Vohra NA, Wong JH, Zervos EE (2015) Dramatic increase in the incidence and mortality from merkel cell carcinoma in the united states. Am Surg 81:802–806PubMed Fitzgerald TL, Dennis S, Kachare SD, Vohra NA, Wong JH, Zervos EE (2015) Dramatic increase in the incidence and mortality from merkel cell carcinoma in the united states. Am Surg 81:802–806PubMed
Zurück zum Zitat Goh G, Walradt T, Markarov V et al (2016) Mutational landscape of MCPyV-positive and MCPyV-negative merkel cell carcinomas with implications for immunotherapy. Oncotarget. 7:3403–3415PubMed Goh G, Walradt T, Markarov V et al (2016) Mutational landscape of MCPyV-positive and MCPyV-negative merkel cell carcinomas with implications for immunotherapy. Oncotarget. 7:3403–3415PubMed
Zurück zum Zitat Kaae J, Boyd HA, Hansen AV, Wulf HC, Wohlfahrt J, Melbye M (2010) Photosensitizing medication use and risk of skin cancer. Cancer Epidemiol Biomarkers Prev. 19:2942–2949CrossRefPubMed Kaae J, Boyd HA, Hansen AV, Wulf HC, Wohlfahrt J, Melbye M (2010) Photosensitizing medication use and risk of skin cancer. Cancer Epidemiol Biomarkers Prev. 19:2942–2949CrossRefPubMed
Zurück zum Zitat Koljonen V, Kluger N, Sihto H, Böhling T (2013) Lateral distribution of Merkel cell carcinoma in a nationwide cohort. J Eur Acad Dermatol Venereol 27:884–888CrossRefPubMed Koljonen V, Kluger N, Sihto H, Böhling T (2013) Lateral distribution of Merkel cell carcinoma in a nationwide cohort. J Eur Acad Dermatol Venereol 27:884–888CrossRefPubMed
Zurück zum Zitat Lebbe C, Becker JC, Grob JJ, Malvehy J, Del Marmol V, Pehamberger H, Peris K, Saiag P, Middleton MR, Bastholt L, Testori A, Stratigos A, Garbe C (2015) European Dermatology Forum (EDF), the European Association of Dermato-Oncology (EADO) and the European Organization for Research and Treatment of Cancer (EORTC). Diagnosis and treatment of Merkel Cell Carcinoma. European consensus-based interdisciplinary guideline. Eur J Cancer 51:2396–2403CrossRefPubMed Lebbe C, Becker JC, Grob JJ, Malvehy J, Del Marmol V, Pehamberger H, Peris K, Saiag P, Middleton MR, Bastholt L, Testori A, Stratigos A, Garbe C (2015) European Dermatology Forum (EDF), the European Association of Dermato-Oncology (EADO) and the European Organization for Research and Treatment of Cancer (EORTC). Diagnosis and treatment of Merkel Cell Carcinoma. European consensus-based interdisciplinary guideline. Eur J Cancer 51:2396–2403CrossRefPubMed
Zurück zum Zitat Paulson KG, Iyer JG, Nghiem P (2011) Asymmetric lateral distribution of melanoma and Merkel cell carcinoma in the United States. J Am Acad Dermatol 65:35–39CrossRefPubMedPubMedCentral Paulson KG, Iyer JG, Nghiem P (2011) Asymmetric lateral distribution of melanoma and Merkel cell carcinoma in the United States. J Am Acad Dermatol 65:35–39CrossRefPubMedPubMedCentral
Zurück zum Zitat Popp S, Waltering S, Herbst C, Moll I, Boukamp P (2002) UV-B-type mutations and chromosomal imbalances indicate common pathways for the development of Merkel and skin squamous cell carcinomas. Int J Cancer 99:352–360CrossRefPubMed Popp S, Waltering S, Herbst C, Moll I, Boukamp P (2002) UV-B-type mutations and chromosomal imbalances indicate common pathways for the development of Merkel and skin squamous cell carcinomas. Int J Cancer 99:352–360CrossRefPubMed
Zurück zum Zitat Quail DF, Siegers GM, Jewer M, Postovit LM (2013) Nodal signalling in embryogenesis and tumourigenesis. Int J Biochem Cell Biol 45:885–898CrossRefPubMed Quail DF, Siegers GM, Jewer M, Postovit LM (2013) Nodal signalling in embryogenesis and tumourigenesis. Int J Biochem Cell Biol 45:885–898CrossRefPubMed
Zurück zum Zitat Raya A, Kawakami Y, Rodriguez-Esteban C, Buscher D, Koth CM, Itoh T, Morita M, Raya RM, Dubova I, Bessa JG, de la Pompa JL, Izpisua Belmonte JC (2003) Notch activity induces Nodal expression and mediates the establishment of left-right asymmetry in vertebrate embryos. Genes Dev 17:1213–1218CrossRefPubMedPubMedCentral Raya A, Kawakami Y, Rodriguez-Esteban C, Buscher D, Koth CM, Itoh T, Morita M, Raya RM, Dubova I, Bessa JG, de la Pompa JL, Izpisua Belmonte JC (2003) Notch activity induces Nodal expression and mediates the establishment of left-right asymmetry in vertebrate embryos. Genes Dev 17:1213–1218CrossRefPubMedPubMedCentral
Zurück zum Zitat Roychoudhuri R, Putcha V, Moller H (2006) Cancer and laterality: a study of the five major paired organs (UK). Cancer Causes Contr 17:655–662CrossRef Roychoudhuri R, Putcha V, Moller H (2006) Cancer and laterality: a study of the five major paired organs (UK). Cancer Causes Contr 17:655–662CrossRef
Zurück zum Zitat Shen MM (2007) Nodal signaling: developmental roles and regulation. Development 134:1023–1034CrossRefPubMed Shen MM (2007) Nodal signaling: developmental roles and regulation. Development 134:1023–1034CrossRefPubMed
Zurück zum Zitat Shiratori H, Hamada H (2014) TGFβ signaling in establishing left-right asymmetry. Semin Cell Dev Biol 32:80–84CrossRefPubMed Shiratori H, Hamada H (2014) TGFβ signaling in establishing left-right asymmetry. Semin Cell Dev Biol 32:80–84CrossRefPubMed
Zurück zum Zitat Sihto H, Kukko H, Koljonen V, Sankila R, Böhling T, Joensuu H (2009) Clinical factors associated with Merkel cell polyomavirus infection in Merkel cell carcinoma. J Natl Cancer Inst 101:938–945CrossRefPubMed Sihto H, Kukko H, Koljonen V, Sankila R, Böhling T, Joensuu H (2009) Clinical factors associated with Merkel cell polyomavirus infection in Merkel cell carcinoma. J Natl Cancer Inst 101:938–945CrossRefPubMed
Zurück zum Zitat Topczewska JM, Postovit LM, Margaryan NV et al (2006) Embryonic and tumorigenic pathways converge via nodal signaling: role in melanoma aggressiveness. Nat Med 12:925–932CrossRefPubMed Topczewska JM, Postovit LM, Margaryan NV et al (2006) Embryonic and tumorigenic pathways converge via nodal signaling: role in melanoma aggressiveness. Nat Med 12:925–932CrossRefPubMed
Zurück zum Zitat Tuorkey MJ (2015) Solar ultraviolet radiation from cancer induction to cancer prevention: solar ultraviolet radiation and cell biology. Eur J Cancer Prev 24:430–438CrossRefPubMed Tuorkey MJ (2015) Solar ultraviolet radiation from cancer induction to cancer prevention: solar ultraviolet radiation and cell biology. Eur J Cancer Prev 24:430–438CrossRefPubMed
Zurück zum Zitat Wieland U, Scola N, Stolte B, Stücker M, Silling S, Kreuter A (2012) No evidence for a causal role of Merkel cell polyomavirus in keratoacanthoma. J Am Acad Dermatol 67:41–46CrossRefPubMed Wieland U, Scola N, Stolte B, Stücker M, Silling S, Kreuter A (2012) No evidence for a causal role of Merkel cell polyomavirus in keratoacanthoma. J Am Acad Dermatol 67:41–46CrossRefPubMed
Zurück zum Zitat Wong SQ, Waldeck K, Vergara IA et al (2015) UV-associated mutations underlie the etiology of MCV-negative merkel cell carcinomas. Cancer Res 75:5228–5234CrossRefPubMed Wong SQ, Waldeck K, Vergara IA et al (2015) UV-associated mutations underlie the etiology of MCV-negative merkel cell carcinomas. Cancer Res 75:5228–5234CrossRefPubMed
Zurück zum Zitat Youlden DR, Soyer HP, Youl PH, Fritschi L, Baade PD (2014) Incidence and survival for merkel cell carcinoma in Queensland, Australia, 1993-2010. JAMA Dermatol. 150:864–872CrossRefPubMed Youlden DR, Soyer HP, Youl PH, Fritschi L, Baade PD (2014) Incidence and survival for merkel cell carcinoma in Queensland, Australia, 1993-2010. JAMA Dermatol. 150:864–872CrossRefPubMed
Metadaten
Titel
Left-sided laterality of Merkel cell carcinoma in a German population: more than just sun exposure
verfasst von
T. Gambichler
U. Wieland
S. Silling
M. Dreißigacker
J. Schaller
H.-J. Schulze
F. Oellig
A. Kreuter
M. Stücker
F. G. Bechara
E. Stockfleth
J. C. Becker
Publikationsdatum
24.10.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Cancer Research and Clinical Oncology / Ausgabe 2/2017
Print ISSN: 0171-5216
Elektronische ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-016-2293-2

Weitere Artikel der Ausgabe 2/2017

Journal of Cancer Research and Clinical Oncology 2/2017 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.